I-4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Purity ≥99.5% (GC) I-Factory Hot Sale

Incazelo emfushane:

Igama Lekhemikhali: 4,6-Dichloro-2-Methylpyrimidine

CAS: 1780-26-3

Ubumsulwa: ≥99.5% (GC)

Ukubukeka: I-Crystalline Powder Emhlophe noma Engamhlophe

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Okumaphakathi kwe-Dasatinib / Moxonidine

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Igama Lekhemikhali	4,6-Dichloro-2-Methylpyrimidine
Omqondofana	I-2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine
Inombolo ye-CAS	1780-26-3
Inombolo yeCAT	I-RF-PI687
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C5H4Cl2N2
Isisindo samangqamuzana	163.00
I-Melting Point	41.5~45.5℃ (okhanyisiwe)
I-Solubility (I-Soluble in)	I-Methanol
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Emhlophe noma Engamhlophe
Ukuhlanzeka / Indlela Yokuhlaziya	≥99.5% (GC)
Ukulahlekelwa Ekumisweni	≤0.50%
Izinsalela Ekushiseni	≤0.20%
Ukungcola Okukodwa	≤0.50%
Ukungcola Okuphelele	≤0.50%
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediate;I-Dasatinib/Moxonidine Intermediate

I-4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Umzila Wenqubo

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-4,6-Dichloro-2-Methylpyrimidine (i-CAS: 1780-26-3) isetshenziselwa ukuhlanganiswa kwama-intermediates emithi kanye nama-API.Imikhiqizo Yokulungiselela: I-Moxonidine (i-CAS: 75438-57-2);I-Dasatinib (CAS: 302962-49-8);I-Dasatinib Monohydrate (CAS: 863127-77-9);I-4-Chloro-2,6-Dimethylpyrimidine (i-CAS: 4472-45-1);I-4-Amino-6-Chloro-2-Methylpyrimidine (i-CAS: 1749-68-4).I-Moxonidine uhlobo olusha lomuthi we-antihypertensive, ovame ukusetshenziswa ekwelapheni umfutho wegazi ophakeme obalulekile.Uma kuqhathaniswa nama-antihypertensive amadala asebenza phakathi nendawo, i-Moxonidine ibopha ngokusondelana okukhulu kakhulu ne-imidazoline I1-receptor kune-α2-receptor.I-Dasatinib iyi-oral enamandla ye-oncogenic kinase inhibitor, engavimba isignali yokusheshisa ukuphindaphinda kwamangqamuzana omdlavuza, ngoMeyi 2009, i-US Food and Drug Administration (FDA) yagunyaza ngokusemthethweni ukudayiswa kwe-dasatinib, iye yasetshenziselwa ukwelashwa kwezifo ezihlukahlukene ezingapheli. i-myeloid leukemia (CML), okuhlanganisa nokwelashwa kwe-myeloid leukemia engapheli engazweli noma engabekezeleli ezinhlelweni zokwelapha ezihlanganisa imatinib mesylate., Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + BONKE) kanye nokwelashwa kweziguli ezinezimila eziqinile.